DLBCL, NOS GENETIC SUBTYPES

Clinical trials for DLBCL, NOS GENETIC SUBTYPES explained in plain language.

Never miss a new study

Get alerted when new DLBCL, NOS GENETIC SUBTYPES trials appear

Sign up with your email to follow new studies for DLBCL, NOS GENETIC SUBTYPES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Scientists test new Two-Pronged attack on tough blood cancers

Disease control Recruiting now

This is a small, early-stage study for adults with B-cell leukemia or lymphoma that has come back or not responded to other treatments. The goal is to test the safety of a new two-step approach. First, patients receive a targeted radioactive drug (131-I apamistamab), followed by …

Matched conditions: DLBCL, NOS GENETIC SUBTYPES

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 06, 2026 15:37 UTC

DLBCL, NOS GENETIC SUBTYPES

Get alerted when new DLBCL, NOS GENETIC SUBTYPES trials appear

Scientists test new Two-Pronged attack on tough blood cancers